Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.44) by 47.73 percent. This is a 43.9 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $25.831 million which beat the analyst consensus estimate of $25.150 million by 2.71 percent. This is a 28.14 percent increase over sales of $20.159 million the same period last year.